Bryan R. Meade, Ph.D.

Affiliations: 
2010 Biomedical Sciences University of California, San Diego, La Jolla, CA 
Area:
Biochemistry
Google:
"Bryan Meade"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Steven Dowdy grad student 2010 UCSD
 (Synthesis of bioreversible, phosphotriester-modified siRNA oligonucleotides.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hagopian JC, Hamil AS, van den Berg A, et al. (2017) Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers. Nucleic Acid Therapeutics
Kaulich M, Lee YJ, Lönn P, et al. (2015) Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi. Nucleic Acids Research. 43: e45
Meade BR, Gogoi K, Hamil AS, et al. (2014) Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications. Nature Biotechnology. 32: 1256-61
Meade BR, Dowdy SF. (2009) The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla. Discovery Medicine. 8: 253-6
Eguchi A, Meade BR, Chang YC, et al. (2009) Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nature Biotechnology. 27: 567-71
Hagopian JC, Ma CT, Meade BR, et al. (2008) Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1. Journal of Molecular Biology. 382: 894-909
Meade BR, Dowdy SF. (2008) Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Advanced Drug Delivery Reviews. 60: 530-6
Meade BR, Dowdy SF. (2007) Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Advanced Drug Delivery Reviews. 59: 134-40
Snyder EL, Saenz CC, Denicourt C, et al. (2005) Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides. Cancer Research. 65: 10646-50
Snyder EL, Meade BR, Saenz CC, et al. (2004) Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. Plos Biology. 2: E36
See more...